Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 5
2021 3
2022 3
2023 1
2024 7

Text availability

Article attribute

Article type

Publication date

Search Results

19 results

Results by year

Filters applied: . Clear all
Page 1
Durable responses to ATR inhibition with ceralasertib in tumors with genomic defects and high inflammation.
Dillon MT, Guevara J, Mohammed K, Patin EC, Smith SA, Dean E, Jones GN, Willis SE, Petrone M, Silva C, Thway K, Bunce C, Roxanis I, Nenclares P, Wilkins A, McLaughlin M, Jayme-Laiche A, Benafif S, Nintos G, Kwatra V, Grove L, Mansfield D, Proszek P, Martin P, Moore L, Swales KE, Banerji U, Saunders MP, Spicer J, Forster MD, Harrington KJ. Dillon MT, et al. Among authors: nenclares p. J Clin Invest. 2024 Jan 16;134(2):e175369. doi: 10.1172/JCI175369. J Clin Invest. 2024. PMID: 37934611 Free PMC article. Clinical Trial.
Management of Head and Neck Mucosal Melanoma.
Nenclares P, Harrington KJ. Nenclares P, et al. Oral Maxillofac Surg Clin North Am. 2022 May;34(2):299-314. doi: 10.1016/j.coms.2021.11.008. Epub 2022 Apr 8. Oral Maxillofac Surg Clin North Am. 2022. PMID: 35400572 Review.
Harnessing radiotherapy-induced NK-cell activity by combining DNA damage-response inhibition and immune checkpoint blockade.
Patin EC, Dillon MT, Nenclares P, Grove L, Soliman H, Leslie I, Northcote D, Bozhanova G, Crespo-Rodriguez E, Baldock H, Whittock H, Baker G, Kyula J, Guevara J, Melcher AA, Harper J, Ghadially H, Smith S, Pedersen M, McLaughlin M, Harrington KJ. Patin EC, et al. Among authors: nenclares p. J Immunother Cancer. 2022 Mar;10(3):e004306. doi: 10.1136/jitc-2021-004306. J Immunother Cancer. 2022. PMID: 35314434 Free PMC article.
Head and Neck Cancer: United Kingdom National Multidisciplinary Guidelines, Sixth Edition.
Homer JJ, Winter SC, Abbey EC, Aga H, Agrawal R, Ap Dafydd D, Arunjit T, Axon P, Aynsley E, Bagwan IN, Batra A, Begg D, Bernstein JM, Betts G, Bicknell C, Bisase B, Brady GC, Brennan P, Brunet A, Bryant V, Cantwell L, Chandra A, Chengot P, Chua MLK, Clarke P, Clunie G, Coffey M, Conlon C, Conway DI, Cook F, Cooper MR, Costello D, Cosway B, Cozens NJA, Creaney G, Gahir DK, Damato S, Davies J, Davies KS, Dragan AD, Du Y, Edmond MRD, Fedele S, Finze H, Fleming JC, Foran BH, Fordham B, Foridi MMAS, Freeman L, Frew KE, Gaitonde P, Gallyer V, Gibb FW, Gore SM, Gormley M, Govender R, Greedy J, Urbano TG, Gujral D, Hamilton DW, Hardman JC, Harrington K, Holmes S, Homer JJ, Howland D, Humphris G, Hunter KD, Ingarfield K, Irving R, Isand K, Jain Y, Jauhar S, Jawad S, Jenkins GW, Kanatas A, Keohane S, Kerawala CJ, Keys W, King EV, Kong A, Lalloo F, Laws K, Leong SC, Lester S, Levy M, Lingley K, Madani G, Mani N, Matteucci PL, Mayland CR, McCaul J, McCaul LK, McDonnell P, McPartlin A, Mercadante V, Merchant Z, Mihai R, Moonim MT, Moore J, Nankivell P, Natu S, Nelson A, Nenclares P, Newbold K, Newland C, Nicol AJ, Nixon IJ, Obholzer R, O'Hara JT, Orr S, Paleri V, Palmer J, Parry RS, Pat… See abstract for full author list ➔ Homer JJ, et al. Among authors: nenclares p. J Laryngol Otol. 2024 Apr;138(S1):S1-S224. doi: 10.1017/S0022215123001615. Epub 2024 Mar 14. J Laryngol Otol. 2024. PMID: 38482835 Free article. No abstract available.
Head and neck mucosal melanoma: The United Kingdom national guidelines.
Nenclares P, Ap Dafydd D, Bagwan I, Begg D, Kerawala C, King E, Lingley K, Paleri V, Paterson G, Payne M, Silva P, Steven N, Turnbull N, Yip K, Harrington KJ. Nenclares P, et al. Eur J Cancer. 2020 Oct;138:11-18. doi: 10.1016/j.ejca.2020.07.017. Epub 2020 Aug 20. Eur J Cancer. 2020. PMID: 32829104 Review.
Sculpting the tumour microenvironment by combining radiotherapy and ATR inhibition for curative-intent adjuvant immunotherapy.
Patin EC, Nenclares P, Chan Wah Hak C, Dillon MT, Patrikeev A, McLaughlin M, Grove L, Foo S, Soliman H, Barata JP, Marsden J, Baldock H, Gkantalis J, Roulstone V, Kyula J, Burley A, Hubbard L, Pedersen M, Smith SA, Clancy-Thompson E, Melcher AA, Ono M, Rullan A, Harrington KJ. Patin EC, et al. Among authors: nenclares p. Nat Commun. 2024 Aug 13;15(1):6923. doi: 10.1038/s41467-024-51236-6. Nat Commun. 2024. PMID: 39134540 Free PMC article.
Looking a Gift Horse in the Mouth: Observations on NHS England's Interim Guidance on Pembrolizumab in Head and Neck Squamous Cell Cancer.
Harrington KJ, Bhide SA, Forster MD, Good JS, Gunn L, Kong A, Melcher AA, Metcalf R, Nenclares P, Newbold KL, Nutting CM, Prestwich R, Sacco JJ, Soliman H, Wong KH. Harrington KJ, et al. Among authors: nenclares p. Clin Oncol (R Coll Radiol). 2020 Aug;32(8):490-492. doi: 10.1016/j.clon.2020.05.016. Epub 2020 Jun 6. Clin Oncol (R Coll Radiol). 2020. PMID: 32513517 Free PMC article. No abstract available.
19 results